Evrima Technologies
Leichhardt
About Evrima Technologies
Evrima Technologies provides clinical trial recruitment solutions to speed up research and bring new treatments to patients in need. Evrima Technologies has a global impact on clinical trial timelines, allowing the industry to advance medical research more quickly, and allowing people to access the therapies they require. Evrima Technologies is on a mission to help advance medical development by accelerating patient identification and recruitment. Evrima Technologies reduces the administrative burden on researchers, allowing them to focus on the high-value clinical work required to get new medicines from bench to bedside.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: evrima.com.au
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/evrima-technologies-145369 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.